--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About BMRN20260220P55
Pharmaceutical
Biomarin Pharmaceutical Inc., was incorporated in Delaware in October 1996 and commenced operations on March 21, 1997. The company is a global biotechnology company that transforms the promise of genetic discovery into drugs that have a profound impact on the lives of every patient. T. BioMarin selects product candidates for diseases and conditions representing significant unmet medical needs that have a good biological understanding and provide opportunities to be the first to market or offer advantages over existing products. The company's product portfolio consists of four approved products and multiple research candidates.
